Camptosar

Irinotecan hydrochloride hydrate is a hydrate that is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Irinotecan hydrochloride hydrate, CPT-11 Trihydrate, Onivyde (TN) and Campto (TN). Its PubChem CID is 60837.

CAS No 136572-09-3
Molecular Formula C33H45ClN4O9
Molecular Weight 677.2 g/mol
Synonyms [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride

Frequently Asked Questions